Literature DB >> 10234039

Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor.

B A Horger1, C A Iyasere, M T Berhow, C J Messer, E J Nestler, J R Taylor.   

Abstract

The mesolimbic dopamine (DA) system has been implicated in drug reward, locomotor sensitization, and responding for reward-related stimuli [termed conditioned reinforcers (CR)]. Here, we investigated the effect of brain-derived neurotrophic factor (BDNF), which enhances the survival and function of dopaminergic neurons, on stimulant-induced locomotor sensitization and responding for CR. In experiment 1, BDNF was infused into the nucleus accumbens (NAc) or ventral tegmental area over 2 weeks via chronically implanted minipumps (1-2.5 microgram/d), and the psychomotor stimulant effects of cocaine (5-15 mg/kg, i.p.) were studied. We found that BDNF enhanced the initial stimulant effects of cocaine and seemed to facilitate the development of sensitization to repeated cocaine doses. In experiment 2, we studied the effects of intra-NAc BDNF infusions on responding for CR. BDNF-treated rats showed twice as many CR responses compared with controls when saline was first administered. BDNF enhanced responding on the CR lever more than four times that seen in control animals after a cocaine injection (10 mg/kg, i.p.). The enhanced response to cocaine in BDNF-treated animals persisted for more than a month after the BDNF infusions had stopped, indicating long-lasting changes in the mesolimbic DA system caused by BDNF administration. In experiment 3, we examined locomotor sensitization to cocaine in heterozygous BDNF knock-out mice and found that the development of sensitization was delayed compared with wild-type littermates. These results demonstrate the profound effects of BDNF on the enhancement of both cocaine-induced locomotion and facilitation of CR and suggest a possible role for BDNF in long-term adaptations of the brain to cocaine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10234039      PMCID: PMC6782687     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  69 in total

1.  Dopamine and conditioned reinforcement. I. Differential effects of amphetamine microinjections into striatal subregions.

Authors:  A E Kelley; J M Delfs
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Immunohistochemical localization of brain-derived neurotrophic factor in adult rat brain.

Authors:  Y Kawamoto; S Nakamura; S Nakano; N Oka; I Akiguchi; J Kimura
Journal:  Neuroscience       Date:  1996-10       Impact factor: 3.590

3.  Involvement of the ventral tegmental dopamine system in opioid and psychomotor stimulant reinforcement.

Authors:  M A Bozarth; R A Wise
Journal:  NIDA Res Monogr       Date:  1986

4.  Spontaneous behaviours of rats are differentially affected by substantia nigra infusions of brain-derived neurotrophic factor and neurotrophin-3.

Authors:  M T Martin-Iverson; C A Altar
Journal:  Eur J Neurosci       Date:  1996-08       Impact factor: 3.386

5.  Increased expression of trkB mRNA in rat caudate--putamen following 6-OHDA lesions of the nigrostriatal pathway.

Authors:  S Numan; K B Seroogy
Journal:  Eur J Neurosci       Date:  1997-03       Impact factor: 3.386

6.  The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression.

Authors:  H C Hung; E H Lee
Journal:  Brain Res Mol Brain Res       Date:  1996-09-05

7.  BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra.

Authors:  C Hyman; M Hofer; Y A Barde; M Juhasz; G D Yancopoulos; S P Squinto; R M Lindsay
Journal:  Nature       Date:  1991-03-21       Impact factor: 49.962

Review 8.  Molecular mechanisms of drug addiction: adaptations in signal transduction pathways.

Authors:  E J Nestler; M T Berhow; E S Brodkin
Journal:  Mol Psychiatry       Date:  1996-07       Impact factor: 15.992

9.  Comparative study of brain-derived neurotrophic factor messenger RNA and protein at the cellular level suggests multiple roles in hippocampus, striatum and cortex.

Authors:  R Schmidt-Kastner; C Wetmore; L Olson
Journal:  Neuroscience       Date:  1996-09       Impact factor: 3.590

10.  Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts.

Authors:  H Sauer; W Fischer; G Nikkhah; S J Wiegand; P Brundin; R M Lindsay; A Björklund
Journal:  Brain Res       Date:  1993-10-29       Impact factor: 3.252

View more
  126 in total

1.  Role for GDNF in biochemical and behavioral adaptations to drugs of abuse.

Authors:  C J Messer; A J Eisch; W A Carlezon; K Whisler; L Shen; D H Wolf; H Westphal; F Collins; D S Russell; E J Nestler
Journal:  Neuron       Date:  2000-04       Impact factor: 17.173

2.  Brain-derived neurotrophic factor controls dopamine D3 receptor expression: implications for neurodevelopmental psychiatric disorders.

Authors:  Pierre Sokoloff; Olivier Guillin; Jorge Diaz; Patrick Carroll; Nathalie Griffon
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

3.  Alcohol induced depressive-like behavior is associated with a reduction in hippocampal BDNF.

Authors:  Sheketha R Hauser; Bruk Getachew; Robert E Taylor; Yousef Tizabi
Journal:  Pharmacol Biochem Behav       Date:  2011-09-10       Impact factor: 3.533

Review 4.  Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability.

Authors:  R Andrew Chambers; Jane R Taylor; Marc N Potenza
Journal:  Am J Psychiatry       Date:  2003-06       Impact factor: 18.112

Review 5.  Neurotrophic mechanisms in drug addiction.

Authors:  Carlos A Bolaños; Eric J Nestler
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

6.  BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression.

Authors:  George S Alexopoulos; Charles E Glatt; Matthew J Hoptman; Dora Kanellopoulos; Christopher F Murphy; Robert E Kelly; Sarah S Morimoto; Kelvin O Lim; Faith M Gunning
Journal:  J Affect Disord       Date:  2010-03-25       Impact factor: 4.839

7.  Viral depletion of VTA BDNF in rats modulates social behavior, consequences of intermittent social defeat stress, and long-term weight regulation.

Authors:  Sanya Fanous; Ernest F Terwilliger; Ronald P Hammer; Ella M Nikulina
Journal:  Neurosci Lett       Date:  2011-08-04       Impact factor: 3.046

Review 8.  A scale-free systems theory of motivation and addiction.

Authors:  R Andrew Chambers; Warren K Bickel; Marc N Potenza
Journal:  Neurosci Biobehav Rev       Date:  2007-05-03       Impact factor: 8.989

9.  Treatment with tianeptine induces antidepressive-like effects and alters the neurotrophin levels, mitochondrial respiratory chain and cycle Krebs enzymes in the brain of maternally deprived adult rats.

Authors:  Franciela P Della; Helena M Abelaira; Gislaine Z Réus; Maria Augusta B dos Santos; Débora B Tomaz; Altamir R Antunes; Giselli Scaini; Meline O S Morais; Emilio L Streck; João Quevedo
Journal:  Metab Brain Dis       Date:  2013-01-18       Impact factor: 3.584

Review 10.  [Brain-derived neurotrophic factor: from nerve growth factor to modulator of brain plasticity in cognitive processes and psychiatric diseases].

Authors:  C Laske; G W Eschweiler
Journal:  Nervenarzt       Date:  2006-05       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.